Aspen Pharmacare Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Aspen Pharmacare Holdings has a total shareholder equity of ZAR85.6B and total debt of ZAR36.1B, which brings its debt-to-equity ratio to 42.2%. Its total assets and total liabilities are ZAR139.3B and ZAR53.7B respectively. Aspen Pharmacare Holdings's EBIT is ZAR8.5B making its interest coverage ratio 8.4. It has cash and short-term investments of ZAR11.6B.
Key information
42.2%
Debt to equity ratio
R36.12b
Debt
Interest coverage ratio | 8.4x |
Cash | R11.60b |
Equity | R85.60b |
Total liabilities | R53.69b |
Total assets | R139.29b |
Recent financial health updates
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Recent updates
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30Financial Position Analysis
Short Term Liabilities: APN's short term assets (ZAR44.0B) exceed its short term liabilities (ZAR22.9B).
Long Term Liabilities: APN's short term assets (ZAR44.0B) exceed its long term liabilities (ZAR30.7B).
Debt to Equity History and Analysis
Debt Level: APN's net debt to equity ratio (28.6%) is considered satisfactory.
Reducing Debt: APN's debt to equity ratio has reduced from 121.2% to 42.2% over the past 5 years.
Debt Coverage: APN's debt is not well covered by operating cash flow (17.4%).
Interest Coverage: APN's interest payments on its debt are well covered by EBIT (8.4x coverage).